Mérieux, a world leader in the field of in vitro diagnostics, today announces the launch of GENE-UP® PROBIOTIC SPECIES ID, a ...

Seegene is launching the Global Million Clinical Study at the scale of one million test cases to shape disease-specific testing standards.The study is designed to evaluate the clinical utility of ...

Visby's multi-viral Medical Flu and Covid-19 test yields results in 30 minutes.

Visby Medical, the at-home diagnostics company, today announced U.S. Food and Drug Administration (FDA) clearance for the ...

A cluster-randomized clinical trial finds that adoption of onsite polymerase chain reaction (PCR) testing for COVID-19, ...

The use of point-of-care respiratory multiplex polymerase chain reaction (POC-RMPCR) in nursing homes did not affect the ...

Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures ...

Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

Mucor PCR testing of bronchoalveolar lavage (BAL) fluid showed high specificity in identifying invasive pulmonary mucormycosis (IPM) in lung transplant recipients, especially when used in conjunction ...

These tests have very limited clinical use. The need for antibody testing would be to determine if a patient has recovered from COVID-19, and whether we could take a sample of the patient’s plasma to ...

Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...